The HPV Prevention and Control Board, founded in 2015, is an independent group of international experts that bring together key professionals, groups and government officials to deal with issues related to screening and prevention programmes for human papillomavirus (HPV) infection, the persistence of which may lead to cervical cancer, the second most common cancer in women living in low-resource settings. The Board focusses on preventing cervical cancer in these countries by promoting the sharing of information on cervical screening and HPV vaccination, which by 2014 had reached only around 3% of eligible girls in low income countries.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - HPV Prevention and Control Board (en)
|
rdfs:comment
| - The HPV Prevention and Control Board, founded in 2015, is an independent group of international experts that bring together key professionals, groups and government officials to deal with issues related to screening and prevention programmes for human papillomavirus (HPV) infection, the persistence of which may lead to cervical cancer, the second most common cancer in women living in low-resource settings. The Board focusses on preventing cervical cancer in these countries by promoting the sharing of information on cervical screening and HPV vaccination, which by 2014 had reached only around 3% of eligible girls in low income countries. (en)
|
foaf:name
| - HPV Prevention and Control Board (en)
|
foaf:homepage
| |
name
| - HPV Prevention and Control Board (en)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
caption
| - Human papillomavirus type 11, associated with anogenital warts and protected from in some HPV vaccines. (en)
|
formation
| |
headquarters
| - Vaccine and Infectious Disease Institute of the University of Antwerp (en)
|
logo
| - HPV Prevention and Control Board logo.jpg (en)
|
logo caption
| - HPV Prevention and Control Board logo (en)
|
website
| |
has abstract
| - The HPV Prevention and Control Board, founded in 2015, is an independent group of international experts that bring together key professionals, groups and government officials to deal with issues related to screening and prevention programmes for human papillomavirus (HPV) infection, the persistence of which may lead to cervical cancer, the second most common cancer in women living in low-resource settings. The Board focusses on preventing cervical cancer in these countries by promoting the sharing of information on cervical screening and HPV vaccination, which by 2014 had reached only around 3% of eligible girls in low income countries. The Board is located at the Vaccine and Infectious Disease Institute of the University of Antwerp and its website is a member of the World Health Organization (WHO) led project Vaccine Safety Net (VSN). Local policy-makers can take advice and assistance from the Board on introducing and extending programmes, and by taking into consideration recommendations by the WHO, the Board can facilitate political backing required for their application. One example of their work was in 2018 when the Board contributed to efforts to regain confidence in vaccines for cervical cancer in Columbia following a sudden nationwide drop in uptake of the vaccine's first and second dose from 98% and 88% in 2012 to 14% and 5% in 2016. (en)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is foaf:primaryTopic
of | |